Suze Call: Gail, Arkansas
Gail wants to know whether a 529 or whole life insurance policy is the best way to save money for her grandson’s college education.
Gail wants to know whether a 529 or whole life insurance policy is the best way to save money for her grandson’s college education.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fast Money ‘Fast Money’ traders Dan Nathan and Tim Seymour reveal their 2024 acronym stock groups they are watching. 05:11 Mon, Jan 8 20246:17 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email NBC News’ Chuck Todd, NBC News national political correspondent Steve Kornacki and NBC News White House correspondent Kristen Welker, take a look at the current state of the presidential race. CNBC’s Washington correspondent Kayla Tausche and “Squawk Alley” co-anchor Jon Fortt explore…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fred Thiel, Marathon Digital CEO and Mike Belshe, Bitgo CEO, joins ‘Closing Bell Overtime’ to talk the kick off of spot bitcoin ETF trading after SEC approval.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Harsh Kumar, Piper Sandler senior research analyst, joins ‘TechCheck’ to discuss Kumar’s hesitations around Micron’s stock, what would lessen his concerns around Micron and whether the Chips Act is baked in to his rating on Micron. 06:23 Wed, Mar 30 202211:34 AM…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Rick Heitzmann, FirstMark Capital founder & partner, joins ‘Fast Money’ to talk the SEC saying its X account was compromised, security concerns in the online space, the state of AI and more.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.